Reisine T - Search Results

1

Huntington's disease mouse models: unraveling the pathology caused by CAG repeat expansion.

Kaye J, Reisine T, Finkbeiner S. Kaye J, et al. Among authors: reisine t. Fac Rev. 2021 Oct 21;10:77. doi: 10.12703/r/10-77. eCollection 2021. Fac Rev. 2021. PMID: 34746930 Free PMC article. Review.

2

Huntington's disease iPSC models-using human patient cells to understand the pathology caused by expanded CAG repeats.

Kaye J, Reisine T, Finkbeiner S. Kaye J, et al. Among authors: reisine t. Fac Rev. 2022 Jun 28;11:16. doi: 10.12703/r/11-16. eCollection 2022. Fac Rev. 2022. PMID: 35865413 Free PMC article. Review.

3

Cell death assays for neurodegenerative disease drug discovery.

Linsley JW, Reisine T, Finkbeiner S. Linsley JW, et al. Among authors: reisine t. Expert Opin Drug Discov. 2019 Sep;14(9):901-913. doi: 10.1080/17460441.2019.1623784. Epub 2019 Jun 10. Expert Opin Drug Discov. 2019. PMID: 31179783 Free PMC article. Review.

4

Approaches to develop therapeutics to treat frontotemporal dementia.

Elia LP, Reisine T, Alijagic A, Finkbeiner S. Elia LP, et al. Among authors: reisine t. Neuropharmacology. 2020 Apr;166:107948. doi: 10.1016/j.neuropharm.2020.107948. Epub 2020 Jan 8. Neuropharmacology. 2020. PMID: 31962288 Free PMC article. Review.

5

Human kinome drug discovery and the emerging importance of atypical allosteric inhibitors.

Eglen RM, Reisine T. Eglen RM, et al. Among authors: reisine t. Expert Opin Drug Discov. 2010 Mar;5(3):277-90. doi: 10.1517/17460441003636820. Epub 2010 Feb 18. Expert Opin Drug Discov. 2010. PMID: 22823023

6

Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 1: Target Identification and Lead Optimization.

Eglen RM, Reisine T. Eglen RM, et al. Among authors: reisine t. SLAS Technol. 2019 Feb;24(1):3-17. doi: 10.1177/2472630318803277. Epub 2018 Oct 4. SLAS Technol. 2019. PMID: 30286296 Review.

7

Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening.

Eglen R, Reisine T. Eglen R, et al. Among authors: reisine t. Assay Drug Dev Technol. 2011 Apr;9(2):108-24. doi: 10.1089/adt.2010.0305. Epub 2010 Dec 27. Assay Drug Dev Technol. 2011. PMID: 21186936 Review.

8

Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 2: Spheroids, Organoids, and Disease Modeling.

Eglen RM, Reisine T. Eglen RM, et al. Among authors: reisine t. SLAS Technol. 2019 Feb;24(1):18-27. doi: 10.1177/2472630318803275. SLAS Technol. 2019. PMID: 30798678 Review.

9

The current status of drug discovery against the human kinome.

Eglen RM, Reisine T. Eglen RM, et al. Among authors: reisine t. Assay Drug Dev Technol. 2009 Feb;7(1):22-43. doi: 10.1089/adt.2008.164. Assay Drug Dev Technol. 2009. PMID: 19382888 Review.

10

Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screening.

Eglen RM, Bosse R, Reisine T. Eglen RM, et al. Among authors: reisine t. Assay Drug Dev Technol. 2007 Jun;5(3):425-51. doi: 10.1089/adt.2007.062. Assay Drug Dev Technol. 2007. PMID: 17638542 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters